The DePuy ASR replacement recall issued in August 2010 was announced after certain studies linked the DePuy ASR XL Acetabular Hip System and the ASR Hip Resurfacing System to a higher-than-normal failure rate.
An estimated one out of every eight patients who were outfitted with a DePuy ASR metal-on-metal device during hip replacement surgery may need to undergo a painful and costly “revision” surgery to replace the defective device just five years after the initial hip surgery.
The high failure rate of DePuy ASR replacement devices was suspected early on by doctors, as many believed the potentially-defective design of the devices prevented a proper implantation during the initial surgery. Without proper implantation, the DePuy ASR replacement devices may loosen and fail to fully fuse with the femur and hip socket, causing painful and debilitating side effects.
While DePuy Orthopaedics blamed the 2010 recall on “sluggish sales” of the ASR devices, many doctors and lawyers now believe that the company was aware of problems associated with the devices long before the recall. In fact, the devices were withdrawn from the Australian market in 2007 due to a higher-than-normal failure rate, yet the devices continued to be sold in the U.S. for three additional years. Doctors also received warning letters from the company in March 2010, some five months prior to the recall, to notify them of the high failure rates.
If you believe you have been affected by the DePuy ASR Replacement recall and are experiencing adverse side effects as a result of your implant, it is important to speak with an attorney about your rights, prior to signing any paperwork from DePuy Orthopaedics or Johnson & Johnson. You may be eligible to receive compensation for past and future medical bills, exams, surgeries, pain, suffering and lost wages related to the DePuy ASR hip replacement recall.